Diabetes Associated Ophthalmic Treatment Market: Evolution
Diabetes-related eye diseases have attracted enormous attention of the healthcare community at large and primary care providers engaged in classification, diagnosis, and treatment. The global burden of diabetes - economic, social, and health-related - is alarming and continues to grow. It has over the past decades grown unabated in young people and the elderly populations in several developing and developed countries. Key ocular complications include diabetic retinopathy (DR), diabetic cataracts, and dry eye syndrome (DES).
Diabetes mellitus poses high mortality and morbidity due to vascular complications, primarily due to prolonged survival of diabetic patients. Primary care providers have collaborated with ophthalmologists for evaluating and managing diabetes-related risk factors for vision impairment. Several studies have established the role of hyperglycemia in complications of DR.
The growing contribution of diabetes in vision loss and blindness in working-age adults is a key driver for strides in the diabetes associated ophthalmic treatment market. Over the years, the world has witnessed growing burdens of diabetes and DR. The concerns have been growing on the back rise of growing frequency of screening procedures in patients with type 1 and type 2 diabetes.
Expanding operations in future? To get the perfect launch ask for a custom report
Diabetes Associated Ophthalmic Treatment Market: Drivers, Current Prospects, Lucrative Avenues
Per a finding by International Federation of Diabetes (IFD), as many as 642 million people in the world will be living with diabetes in 2040. Together with the rising incidence, the prevalence of DR will also mount to alarming levels, thus imparting an impetus to DR screening programs.
The social and emotional burden of diabetes-induced vision impairment has spurred diabetics to refer to the ophthalmologists who make them aware of the risk factors in the different stages of the disease. This has bolstered the growth of the diabetes associated ophthalmic treatment market. Expectedly, ocular guidelines pertaining to pathophysiology, diagnosis, and treatment of diabetic retinopathy (DR) have also evolved.
DR has been found to be one the leading causes of blindness especially among adults aged 20–74 years. Its advanced form - diabetic macular edema (DME) - poses a considerable burden on the health of the working population. A better understanding of stage of retinopathy and complications in DR patients has stridently changed the course of diabetes associated ophthalmic treatment market over the past few years.
According to a study published in the NCBI, the reported prevalence of DES in diabetics amounts to 15–33% in those over 65 years of age, where the aging is viewed as an accelerating factor. Consequently, examination of the dry eye has grown in clinical significance, thereby enriching the landscape of diabetes associated ophthalmic treatment market. The growing incidence of dry eye syndrome in patients with diabetes mellitus is worrisome. The trend has steered R&D in understanding ocular surface system/lacrimal function. The research continues to guide treatment strategies of diabetes mellitus associated DES. These are central to interventions for diabetes associated ophthalmic treatments.
Diabetes Associated Ophthalmic Treatment Market: Competition Landscape and Key Developments
Researchers have made a huge progress in identifying downstream immune-inflammatory regulators and proteins causing LFU dysfunction. Players have used these findings to develop better strategies for prevention and treatment regimens. Recommendations by the Working Group of Ocular Health has enriched screening procedures of DR. Players in diabetes associated ophthalmic treatment market. are keen on commercializing new technologies in the early diagnosis of DR.
Some of the key players in the diabetes associated ophthalmic treatment market are Pfizer, Inc, Carl Zeiss Meditec, Novartis AG, Bayer AG, and Johnson & Johnson Services, Inc.
Request a sample to get extensive insights into the Diabetes Associated Ophthalmic Treatment Market
Diabetes Associated Ophthalmic Treatment Market: Regional Landscape
The Europe is a promisingly lucrative region in the global market. The growth has been fueled by extensive study made in the prevention and treatment strategies for DR and DME. A lot of efforts have bene led by the European Society of Retina Specialists.
North America diabetes associated ophthalmic treatment market has in recent years witnessed substantial revenue streams, led by massive opportunities in the U.S. Rise in demand for screening procedures in patients with type 1 and type 2 diabetes and standardized DR screening programs have led to the development of the regional market.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.